Caredx is trading with a PEG ratio of 0.27, based on Sep 16, 2026 data. Dividing the 24.91 PE ratio by the 92.0% earnings growth rate yields this valuation metric.
Historically, Caredx shows a PEG ratio averaging 0.12 across the past two years. At 0.27, today's PE to growth ratio sits 125% above its historical average. The two years high occurred in the Dec 2024 quarter at 0.17, reflecting maximum valuation relative to growth. The minimum was hit in the Sep 2025 quarter at 0.07, indicating optimal value relative to growth during that period.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | N/A | N/A | -140% |
| 2024 | 0.17 | 21.41 | 128.2% |
| 2023 | N/A | N/A | -145.8% |
| 2022 | N/A | N/A | -144.1% |
| 2021 | N/A | N/A | -47.5% |
| 2020 | N/A | N/A | 23.1% |
| 2019 | N/A | N/A | 60.3% |
| 2018 | N/A | N/A | 45% |
| 2017 | N/A | N/A | 0.4% |
| 2016 | N/A | N/A | -106% |
| 2015 | N/A | N/A | -992.3% |
| 2014 | 0.54 | 55.77 | 103.7% |
| 2013 | N/A | N/A | 30.1% |
| 2012 | N/A | N/A | N/A |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 0.14 | 13.26 | 92% |
| Mar 2026 | N/A | N/A | -113.4% |
| Dec 2025 | N/A | N/A | -140% |
| Sep 2025 | 0.07 | 10.77 | 147% |
| Jun 2025 | 0.13 | 17.45 | 136.1% |
| Mar 2025 | 0.11 | 14.92 | 134.3% |
| Dec 2024 | 0.17 | 21.41 | 128.2% |
| Sep 2024 | N/A | N/A | -70.8% |
| Jun 2024 | N/A | N/A | -97.5% |
| Mar 2024 | N/A | N/A | -128.3% |
| Dec 2023 | N/A | N/A | -145.8% |
| Sep 2023 | N/A | N/A | -19.1% |
| Jun 2023 | N/A | N/A | -18.9% |
| Mar 2023 | N/A | N/A | -60% |
| Dec 2022 | N/A | N/A | -144.1% |
Measured against past performance, CDNA's PEG ratio is higher than its 3, 5 and 10-year averages.
Caredx's PEG of 0.27 is below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 0.51, Caredx's PEG is 47% lower.
According to Sep 16, 2026 data, CDNA's PEG ratio sits at 0.27.
CDNA has a 3-year average PEG ratio of 0.12.
CDNA has a 5-year average PEG ratio of 0.12.
CDNA is currently at its two years PEG ratio peak of 0.27.
Compared to the 2-year average, CDNA's PEG ratio is 125% higher.
The 0.27 PEG ratio for CDNA reflects strong earnings growth outpacing the current valuation.
Computing the PEG ratio involves dividing the PE ratio by the company's EPS growth (YoY TTM). As of Sep 16, 2026, Caredx has a P/E ratio of 24.91. Earnings grew at 92.0% over the TTM period ending Jun 2026. Applying the formula, this produces a price to earnings growth ratio of 0.27. PEG RATIO(0.27) = PE RATIO(24.91) / EPS GROWTH(92.0%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.